UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
19.10
+1.07 (5.93%)
At close: Apr 8, 2026, 4:00 PM EDT
18.72
-0.38 (-1.99%)
After-hours: Apr 8, 2026, 7:31 PM EDT
UroGen Pharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$29.29
Upside
+53.35%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +72.77% | Mar 31, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +72.77% | Mar 2, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +72.77% | Jan 23, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +72.77% | Jan 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +109.42% | Oct 27, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +30.89% | Oct 27, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +30.89% | Oct 3, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $36 | Buy | Initiates | $36 | +88.48% | Aug 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +109.42% | Aug 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +30.89% | Aug 7, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +30.89% | Aug 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +161.78% | Jul 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +30.89% | Jul 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +161.78% | Jun 16, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $31 | Buy | Maintains | $10 → $31 | +62.30% | Jun 13, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $23 → $47 | Buy | Maintains | $23 → $47 | +146.07% | Jun 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.